S. Livia

Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a key off-target activity.

P. Grandi, Christina Rau, M. Bantscheff, 2019, Journal of medicinal chemistry.

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.

P. Jones, P. Rowland, N. Parr, 2015, Journal of medicinal chemistry.

Optimization of Orally Bioavailable PI3K delta Inhibitors and Identification of Vps34 as a Key Selectivity Target.

P. Grandi, Birgit Dümpelfeld, M. Bantscheff, 2020 .

Design and development of arrayable syntheses to accelerate SAR studies of pyridopyrimidinone and pyrimidopyrimidinone

Zehong Wan, Xichen Lin, J. Callahan, 2009 .